Scientists test 'Supercharged' immune cells to fight advanced blood cancers
NCT ID NCT05702853
Summary
This study is testing a new version of a cancer treatment called CAR T-cell therapy for adults with certain B-cell lymphomas or leukemias that have come back or not responded to other treatments. The researchers are modifying a patient's own immune cells in the lab to potentially make them more powerful and longer-lasting against cancer, while also trying to reduce serious side effects. The main goals are to find a safe dose and see how well the treatment works.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC LYMPHOCYTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hollings Cancer Center at Medical University of South Carolina
RECRUITINGCharleston, South Carolina, 29425, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.